| Chronic myeloid leukemia course in persons exposed to ionizing radiation as a result of the chornobyl accident. IS Dyagil, IV Dmytrenko, VV Sholoiko, VG Fedorenko, TY Shlyakhtichenko, ... Problemy Radiatsiinoi Medytsyny ta Radiobiolohii 25, 443-455, 2020 | 2 | 2020 |
| AML-406 Additional Risk Factors of Severe Bleeding in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML): Ukrainian Prospective Study in a Real-Life Cohort Z Stupakova, I Dyagil, Z Martina, A Sergeieva, O Karnabeda, U Melnyk, ... Clinical Lymphoma Myeloma and Leukemia 23, S298, 2023 | | 2023 |
| POSTER: AML-406 Additional Risk Factors of Severe Bleeding in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML): Ukrainian Prospective Study in a Real-Life Cohort Z Stupakova, I Dyagil, Z Martina, A Sergeieva, O Karnabeda, U Melnyk, ... Clinical Lymphoma Myeloma and Leukemia 23, S162, 2023 | | 2023 |
| Primary hemostasis dysfunctions and bleeding risk in newly diagnosed acute myeloid leukemia Z Stupakova, I Diagil, U Melnyk, O Karnabeda, A Sergeieva Journal of Cancer Research and Clinical Oncology 149 (11), 8167-8176, 2023 | | 2023 |
| P590: MODIFICATIONS IN PRIMARY HEMOSTASIS AS ADDITIONAL RISK FACTORS OF BLEEDING IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML): UKRAINIAN PROSPECTIVE STUDY IN A … Z Stupakova, I Dyagil, Z Martina, A Sergeieva, O Karnabeda, U Melnyk, ... HemaSphere 7 (S3), e1795585, 2023 | | 2023 |
| Poster: AML-226 Impairment of Primary Hemostasis as an Additional Risk Factor of Hemorrhage in Patients With Newly Diagnosed Acute Myeloid Leukemia: Ukrainian Prospective Study Z Stupakova, I Dyagil, Z Martina, A Sergeieva, O Karnabeda, U Melnyk, ... Clinical Lymphoma, Myeloma and Leukemia 22, S131, 2022 | | 2022 |
| AML-226 Impairment of Primary Hemostasis as an Additional Risk Factor of Hemorrhage in Patients With Newly Diagnosed Acute Myeloid Leukemia: Ukrainian Prospective Study Z Stupakova, I Dyagil, Z Martina, A Sergeieva, O Karnabeda, U Melnyk, ... Clinical Lymphoma Myeloma and Leukemia 22, S226, 2022 | | 2022 |
| PB1846: ALTERATIONS IN PRIMARY HEMOSTASIS AS ADDITIONAL RISK FACTORS OF BLEEDING IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML): UPDATED PROSPECTIVE ANALYSIS. Z Stupakova, D Iryna, M Zoya, S Anna, O Karnabeda, U Melnyk, ... HemaSphere 6, 1726-1727, 2022 | | 2022 |
| Dysfunctions in primary hemostasis as an additional risk factors of bleeding in patients with newly diagnosed acute myeloid leukemia (AML): Ukrainian prospective analysis. Z Stupakova, I Dyagil, Z Martina, O Karnabeda, U Melnyk, O Novosad AMERICAN JOURNAL OF HEMATOLOGY 96, S5-S6, 2021 | | 2021 |
| MM-250: Pomalidomide in Relapse/Refractory Patients with Multiple Myeloma: A Newly Adopted Approach in Ukraine O Novosad, Z Stupakova, U Melnyk, O Yamenko, N Shokun, I Kriachok Clinical Lymphoma Myeloma and Leukemia 21, S431, 2021 | | 2021 |
| Poster: MM-250: Pomalidomide in Relapse/Refractory Patients with Multiple Myeloma: A Newly Adopted Approach in Ukraine O Novosad, Z Stupakova, U Melnyk, O Yamenko, N Shokun, I Kriachok Clinical Lymphoma Myeloma and Leukemia 21, S255, 2021 | | 2021 |
| Reinforcement of platelets activity in patients with acute myeloid leukemia (AML) and concomitant COVID-19 infection Z Stupakova, I Dyagil, O Karnabeda, H Menzarar Research and Practice in Thrombosis and Haemostasis, 2021 | | 2021 |
| AML-134: Dysfunctions in Primary Hemostasis as Additional Risk Factors of Bleeding in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Z Stupakova, I Dyagil, Z Martina, A Tovstohan, O Karnabeda, U Melnyk, ... Clinical Lymphoma Myeloma and Leukemia 20, S183, 2020 | | 2020 |
